CVX
43
-3
CAT
59
-2
PVH
60
-4
MSFT
48
-9
AEP
54
6
JNJ
41
3
WEC
53
5
MRO
50
4
CFG
74
2
WMT
56
-4
WBA
43
-4
EQT
51
-3
ESS
62
-3
CVS
41
-4
TDC
67
-4
TXN
43
-5
UAL
83
-2
REGN
38
-2
PGR
59
-3
AAP
35
-9
CVX
43
-3
CAT
59
-2
PVH
60
-4
MSFT
48
-9
AEP
54
6
JNJ
41
3
WEC
53
5
MRO
50
4
CFG
74
2
WMT
56
-4
WBA
43
-4
EQT
51
-3
ESS
62
-3
CVS
41
-4
TDC
67
-4
TXN
43
-5
UAL
83
-2
REGN
38
-2
PGR
59
-3
AAP
35
-9
Financhill
Back

RiverNorth/DoubleLine Strategic Opportunity Fund Vs. Avidity Biosciences Industry Stock Comparison

Sell
37

OPP
RiverNorth/DoubleLine Strategic Opportunity Fund

Last Price:
8.37
Seasonality Move:
-1.19%
Sell
28

RNA
Avidity Biosciences

Last Price:
42.16
Seasonality Move:
39.98%
Sell
37
RiverNorth/DoubleLine Strategic Opportunity Fund (OPP) is a Sell

Is RiverNorth/DoubleLine Strategic Opportunity Fund a Buy, Sell or Hold?

  • The current RiverNorth/DoubleLine Strategic Opportunity Fund [OPP] share price is $8.36. The Score for OPP is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • OPP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences a Buy, Sell or Hold?

  • The current Avidity Biosciences [RNA] share price is $42.18. The Score for RNA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • RNA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

OPP Stock Price Chart

What is RiverNorth/DoubleLine Strategic Opportunity Fund's stock price today?

  • The RiverNorth/DoubleLine Strategic Opportunity Fund share price today is $8.36
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OPP is experiencing selling pressure, which indicates risk of future bearish movement.

RNA Stock Price Chart

What is Avidity Biosciences's stock price today?

  • The Avidity Biosciences share price today is $42.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing selling pressure, which indicates risk of future bearish movement.

OPP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 23.91 Sell
Chaikin Money Flow: -181259 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.59 - 8.89) Sell
Bollinger Bands (100): (8.68 - 9.04) Sell

RNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.53 Buy
Relative Strength Index (14 RSI): 42.17 Sell
Chaikin Money Flow: -1839481 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.78 - 48.76) Sell
Bollinger Bands (100): (41.56 - 46.96) Sell

OPP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.61 Sell
20-day SMA: 8.68 Sell
50-day SMA: 8.91 Sell
200-day SMA: 8.64 Sell
8-day EMA: 8.56 Sell
20-day EMA: 8.68 Sell
50-day EMA: 8.8 Sell
200-day EMA: 8.7 Sell

RNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.51 Sell
20-day SMA: 45.87 Sell
50-day SMA: 45.1 Sell
200-day SMA: 34.2 Buy
8-day EMA: 46.84 Sell
20-day EMA: 46.32 Sell
50-day EMA: 45.24 Sell
200-day EMA: 35.58 Buy

RiverNorth/DoubleLine Strategic Opportunity Fund Earnings Growth & OPP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Avidity Biosciences Earnings Growth & RNA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and a decrease next year of $0.25 per share.

RiverNorth/DoubleLine Strategic Opportunity Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Avidity Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):